News
All News
Today
Trending
Tools
Real Time Chart
Forex Heatmap
Stock Heatmap
Crypto Heatmap
Market Data
Economic Calendar
Position Calculator
Categories
Publications
Contact
Login
Eli Lilly’s Obesity Pill Moves Closer to Approval
Markets
·
August 26, 2025
·
Bloomberg
Eli Lilly & Co.’s experimental obesity pill helped patients lose 9.6% of their body weight in a trial that moves the company one step closer to a potential approval. Damian Garde has more on “Bloomberg Open Interest.”
More from
Bloomberg
Markets
Balance of Risks Favors Stock Bulls, Goldman’s Pasquariello Says
November 7, 2025
·
Bloomberg
Markets
Turkey Detains Private Bank Chairman in ‘Loan Shark’ Probe
November 7, 2025
·
Bloomberg
Markets
Europe Should Mull China Action If Situation Worsens, Nagel Says
November 7, 2025
·
Bloomberg
More
Markets
Articles
Markets
Lululemon Cuts Outlook on Weaker Demand, Trade Policies
September 5, 2025
·
Bloomberg
Markets
Gold Stocks Snap 2011 Record High as Investor Angst Intensifies
September 5, 2025
·
Bloomberg
Markets
US LNG Exporters Race to Tie Up Financing as Surplus Looms
September 5, 2025
·
Bloomberg
Trending News
Markets
Turkish Appliance Giant’s Debt Crashes After Second-Quarter Loss
August 20, 2025
·
Bloomberg
Markets
Target Names Insider as CEO to Lead Turnaround
August 20, 2025
·
Bloomberg
Equities
Best Growth Stocks to Buy for August 20th
August 20, 2025
·
Barchart
Enjoy premium content in your inbox.
You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.
